You are being asked to take part in this study because you have liver cancer or cancer that
has spread to the liver are scheduled for SIR-Spheres treatment (Yttrium-90 radioembolization
The goal of this clinical research study is to learn about the safety of giving SIR-Spheres
treatment to patients with liver cancer in the same session rather than over 2 sessions,
which is the standard of care.
This is an investigational study. The SIR-Spheres is delivered using FDA approved and
commercially available methods. It is investigational to learn if the procedure can be safely
performed in a single session.
Up to 12 participants will be enrolled in this study. All will take part at MD Anderson.